Prelude Therapeutics Inc (PRLD) USD0.0001

Sell:$1.27Buy:$1.30$0.28 (31.76%)

NASDAQ:1.03%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.27
Buy:$1.30
Change:$0.28 (31.76%)
Market closed | Prices delayed by at least 15 minutes
Sell:$1.27
Buy:$1.30
Change:$0.28 (31.76%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 December 2024
Krishna (Kris) VaddiCEO
Buy
Regular purchase transaction
6,888$0.89$6,115.86127,553
19 December 2024
Bryant David LimChief Legal/Compliance Officer
Buy
Regular purchase transaction
25,000$0.91$22,637.5027,400
18 December 2024
Krishna (Kris) VaddiCEO
Buy
Regular purchase transaction
100,000$0.93$93,210.001,167,275
4 October 2024
Jane Edna HuangPresident
Sell
Tax related
3,349$2.00$6,698.0063,341
4 July 2024
Jane Edna HuangPresident
Sell
Tax related
3,347$3.60$12,049.2057,315
4 April 2024
Jane Edna HuangPresident
Sell
Tax related
3,347$4.74$15,864.7851,287
4 January 2024
Jane Edna HuangPresident
Sell
Tax related
3,844$3.77$14,491.8845,259

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 December 2024
Krishna (Kris) VaddiCEO
Buy
Regular purchase transaction
100,000$0.93$93,210.001,167,275
19 December 2024
Bryant David LimChief Legal/Compliance Officer
Buy
Regular purchase transaction
25,000$0.91$22,637.5027,400
4 April 2024
Jane Edna HuangPresident
Sell
Tax related
3,347$4.74$15,864.7851,287
4 January 2024
Jane Edna HuangPresident
Sell
Tax related
3,844$3.77$14,491.8845,259
4 July 2024
Jane Edna HuangPresident
Sell
Tax related
3,347$3.60$12,049.2057,315

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.